Literature DB >> 2311207

Radioimmunoassay of type I collagen that mainly detects degradation products in serum: application to patients with liver diseases.

D J Hartmann1, J C Trinchet, S Ricard-Blum, M Beaugrand, P Callard, G Ville.   

Abstract

This radioimmunoassay for type I collagen mainly detects degradation products of the molecule in human serum samples. Type I collagen antigenicity in serum can be separated into two peaks by gel-filtration chromatography. The larger form represents collagen molecules (as shown by immunoblotting experiments), and (or) type I collagen with aminoterminal propeptide or intact procollagen molecules. The smaller form, the exact nature of which is not known, is quantitatively the principal antigenic form and is derived from degradation of type I collagen. The concentration of type I collagen in serum is increased mainly in cirrhotic patients, with or without active liver disease, but also somewhat in alcoholic patients without cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311207

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

1.  Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide.

Authors:  C Hirayama; H Suzuki; A Takada; K Fujisawa; K Tanikawa; S Igarashi
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

2.  Noninvasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables.

Authors:  S Takamatsu; H Nakabayashi; Y Okamoto; H Nakano
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.